Severe hypotension complicating primary angioplasty: allergy to abciximab.
Hawkins
C
C
Department of Clinical Immunology, The Canberra Hospital, P.O. Box 11Woden ACT 2606, Australia. carolyn.hawkins@act.gov.au
Gatenby
P
P
McGill
D
D
D000077284:Abciximab; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation; D017023:Coronary Angiography; D023921:Coronary Stenosis / Q000175:diagnosis / Q000628:therapy; D003875:Drug Eruptions / Q000209:etiology; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000628:therapy; D012720:Severity of Illness Index; D015607:Stents
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab